Patent · US Active

Compositions and methods for inhibiting expression of a gene from the Ebola

US7759320B2 · kind B2 · utility

2Cited by

1References

21Claims

0Family size

Assignee

Alnylam Pharmaceuticals, Inc. · US

Inventors

Sina Bavari · Dillsburg, US
Kelly Lyn Warfield · Adamstown, US
Pamela Tan · Kulmbach, DE
Anna Borodovsky · Cambridge, US
Tatiana Novobrantseva · Cambridge, US
Antonin de Fougerolles · Waterloo, BE

Key dates

Filing date	Mar 25, 2008
Grant date	Jul 20, 2010
Priority date	—
Expiry date	Jun 17, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/3531
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a gene from the Ebola virus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.